Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) EBT Margin (2016)

Rocket Pharmaceuticals (RCKT) has disclosed EBT Margin for 1 consecutive years, with 4248.95% as the latest value for Q4 2016.

  • Quarterly EBT Margin changed N/A to 4248.95% in Q4 2016 from the year-ago period, while the trailing twelve-month figure was 1751.05% through Sep 2017, changed N/A year-over-year, with the annual reading at 1750.98% for FY2015, 86485.0% up from the prior year.
  • EBT Margin hit 4248.95% in Q4 2016 for Rocket Pharmaceuticals, up from 2119.62% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 4917.22% in Q1 2016 to a low of 2119.62% in Q3 2016.